EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
Slovenia · Delayed Price · Currency is EUR 65.50
+1.50 (2.34%)
At close: Oct 9, 2026
EQUINOX NEPREMICNINE d.d. Revenue
EQUINOX NEPREMICNINE d.d. had revenue of 2.46M EUR in the quarter ending June 30, 2026, with 4.76% growth. This brings the company's revenue in the last twelve months to 9.54M, down -1.76% year-over-year. In the year 2025, EQUINOX NEPREMICNINE d.d. had annual revenue of 9.37M with 8.10% growth. That makes EQUINOX NEPREMICNINE d.d. the 37,033rd largest company in the world by revenue and 16th in Slovenia.
Revenue (ttm)
9.54M
Revenue Growth
-1.76%
P/S Ratio
12.31
Revenue / Employee
n/a
Employees
n/a
Market Cap
117.45M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.37M | 702.00K | 8.10% |
| Dec 31, 2024 | 8.67M | 884.07K | 11.35% |
| Dec 31, 2023 | 7.79M | 442.80K | 6.03% |
| Dec 31, 2022 | 7.34M | 629.52K | 9.38% |
| Dec 31, 2021 | 6.71M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SALUS, Ljubljana, d. d. | 758.16M |
| Telekom Slovenije, d.d. | 753.22M |
| UNIOR Kovaska industrija d.d. | 224.18M |
| Cinkarna Celje, d. d. | 191.81M |
| CETIS, Graphic and Documentation Services, d.d. | 117.45M |
| Delavska hranilnica d.d. | 88.24M |
| Terme Catez, d.d. | 40.71M |
| Vzajemna zdravstvena zavarovalnica, d. d. | 35.14M |